ReviewAntioxidants (Basel, Switzerland)2022

NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically.

Ainara González-Moro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.